<?xml version="1.0"?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2014//EN" "http://www.ncbi.nlm.nih.gov/corehtml/query/DTD/pubmed_140101.dtd">
<PubmedArticleSet>

<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25356929</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>10</Month>
            <Day>30</Day>
        </DateCreated>
        <DateRevised>
            <Year>2014</Year>
            <Month>10</Month>
            <Day>31</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1438-8871</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>16</Volume>
                    <Issue>10</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of medical Internet research</Title>
                <ISOAbbreviation>J. Med. Internet Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Rapid Grading of Fundus Photographs for Diabetic Retinopathy Using Crowdsourcing.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e233</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Screening for diabetic retinopathy is both effective and cost-effective, but rates of screening compliance remain suboptimal. As screening improves, new methods to deal with screening data may help reduce the human resource needs. Crowdsourcing has been used in many contexts to harness distributed human intelligence for the completion of small tasks including image categorization.</AbstractText>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Our goal was to develop and validate a novel method for fundus photograph grading.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">An interface for fundus photo classification was developed for the Amazon Mechanical Turk crowdsourcing platform. We posted 19 expert-graded images for grading by Turkers, with 10 repetitions per photo for an initial proof-of-concept (Phase I). Turkers were paid US $0.10 per image. In Phase II, one prototypical image from each of the four grading categories received 500 unique Turker interpretations. Fifty draws of 1-50 Turkers were then used to estimate the variance in accuracy derived from randomly drawn samples of increasing crowd size to determine the minimum number of Turkers needed to produce valid results. In Phase III, the interface was modified to attempt to improve Turker grading.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Across 230 grading instances in the normal versus abnormal arm of Phase I, 187 images (81.3%) were correctly classified by Turkers. Average time to grade each image was 25 seconds, including time to review training images. With the addition of grading categories, time to grade each image increased and percentage of images graded correctly decreased. In Phase II, area under the curve (AUC) of the receiver-operator characteristic (ROC) indicated that sensitivity and specificity were maximized after 7 graders for ratings of normal versus abnormal (AUC=0.98) but was significantly reduced (AUC=0.63) when Turkers were asked to specify the level of severity. With improvements to the interface in Phase III, correctly classified images by the mean Turker grade in four-category grading increased to a maximum of 52.6% (10/19 images) from 26.3% (5/19 images). Throughout all trials, 100% sensitivity for normal versus abnormal was maintained.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">With minimal training, the Amazon Mechanical Turk workforce can rapidly and correctly categorize fundus photos of diabetic patients as normal or abnormal, though further refinement of the methodology is needed to improve Turker ratings of the degree of retinopathy. Images were interpreted for a total cost of US $1.10 per eye. Crowdsourcing may offer a novel and inexpensive means to reduce the skilled grader burden and increase screening for diabetic retinopathy.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Brady</LastName>
                    <ForeName>Christopher J</ForeName>
                    <Initials>CJ</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7847-3914</Identifier>
                    <Affiliation>Wills Eye Hospital, Retina Service: Mid Atlantic Retina, Philadelphia, PA, United States. brady@jhmi.edu.</Affiliation>
                </Author>
                <Author>
                    <LastName>Villanti</LastName>
                    <ForeName>Andrea C</ForeName>
                    <Initials>AC</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-3104-966X</Identifier>
                </Author>
                <Author>
                    <LastName>Pearson</LastName>
                    <ForeName>Jennifer L</ForeName>
                    <Initials>JL</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-1400-5932</Identifier>
                </Author>
                <Author>
                    <LastName>Kirchner</LastName>
                    <ForeName>Thomas R</ForeName>
                    <Initials>TR</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-5764-4980</Identifier>
                </Author>
                <Author>
                    <LastName>Gupta</LastName>
                    <ForeName>Omesh P</ForeName>
                    <Initials>OP</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-4845-0409</Identifier>
                </Author>
                <Author>
                    <LastName>Shah</LastName>
                    <ForeName>Chirag P</ForeName>
                    <Initials>CP</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-6369-4917</Identifier>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>10</Month>
                <Day>30</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Med Internet Res</MedlineTA>
            <NlmUniqueID>100959882</NlmUniqueID>
            <ISSNLinking>1438-8871</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Amazon Mechanical Turk</Keyword>
            <Keyword MajorTopicYN="N">crowdsourcing</Keyword>
            <Keyword MajorTopicYN="N">diabetic retinopathy</Keyword>
            <Keyword MajorTopicYN="N">fundus photography</Keyword>
            <Keyword MajorTopicYN="N">telemedicine</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>9</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>9</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>10</Month>
                <Day>31</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>10</Month>
                <Day>31</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>10</Month>
                <Day>31</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">v16i10e233</ArticleId>
            <ArticleId IdType="doi">10.2196/jmir.3807</ArticleId>
            <ArticleId IdType="pubmed">25356929</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25356875</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>10</Month>
            <Day>30</Day>
        </DateCreated>
        <DateRevised>
            <Year>2014</Year>
            <Month>10</Month>
            <Day>31</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2041-4889</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>5</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Cell death &amp; disease</Title>
                <ISOAbbreviation>Cell Death Dis</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e1506</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi">10.1038/cddis.2014.466</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Long noncoding RNAs (lncRNAs) have important roles in diverse biological processes. Our previous study has revealed that lncRNA-MALAT1 deregulation is implicated in the pathogenesis of diabetes-related microvascular disease, diabetic retinopathy (DR). However, the role of MALAT1 in retinal vasculature remodeling still remains elusive. Here we show that MALAT1 expression is significantly upregulated in the retinas of STZ-induced diabetic rats and db/db mice. MALAT1 knockdown could obviously ameliorate DR in vivo, as shown by pericyte loss, capillary degeneration, microvascular leakage, and retinal inflammation. Moreover, MALAT1 knockdown could regulate retinal endothelial cell proliferation, migration, and tube formation in vitro. The crosstalk between MALAT1 and p38 MAPK signaling pathway is involved in the regulation of endothelial cell function. MALAT1 upregulation represents a critical pathogenic mechanism for diabetes-induced microvascular dysfunction. Inhibition of MALAT1 may serve as a potential target for anti-angiogenic therapy for diabetes-related microvascular complications.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>J-Y</ForeName>
                    <Initials>JY</Initials>
                    <Affiliation>1] Eye Hospital, Nanjing Medical University, Nanjing, China [2] The Fourth School of Clinical Medicine, Nanjing Medical University, Nanjing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yao</LastName>
                    <ForeName>J</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>1] Eye Hospital, Nanjing Medical University, Nanjing, China [2] The Fourth School of Clinical Medicine, Nanjing Medical University, Nanjing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>X-M</ForeName>
                    <Initials>XM</Initials>
                    <Affiliation>Eye Hospital, Nanjing Medical University, Nanjing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Song</LastName>
                    <ForeName>Y-C</ForeName>
                    <Initials>YC</Initials>
                    <Affiliation>1] Eye Hospital, Nanjing Medical University, Nanjing, China [2] The Fourth School of Clinical Medicine, Nanjing Medical University, Nanjing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>X-Q</ForeName>
                    <Initials>XQ</Initials>
                    <Affiliation>1] Eye Hospital, Nanjing Medical University, Nanjing, China [2] The Fourth School of Clinical Medicine, Nanjing Medical University, Nanjing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Y-J</ForeName>
                    <Initials>YJ</Initials>
                    <Affiliation>1] Eye Hospital, Nanjing Medical University, Nanjing, China [2] The Fourth School of Clinical Medicine, Nanjing Medical University, Nanjing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yan</LastName>
                    <ForeName>B</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>1] Eye Hospital, Nanjing Medical University, Nanjing, China [2] The Fourth School of Clinical Medicine, Nanjing Medical University, Nanjing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Jiang</LastName>
                    <ForeName>Q</ForeName>
                    <Initials>Q</Initials>
                    <Affiliation>1] Eye Hospital, Nanjing Medical University, Nanjing, China [2] The Fourth School of Clinical Medicine, Nanjing Medical University, Nanjing, China [3] Institute of Integrated Medicine, Nanjing Medical University, Nanjing, China.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>10</Month>
                <Day>30</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Cell Death Dis</MedlineTA>
            <NlmUniqueID>101524092</NlmUniqueID>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>9</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>9</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>10</Month>
                <Day>31</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>10</Month>
                <Day>31</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>10</Month>
                <Day>31</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">cddis2014466</ArticleId>
            <ArticleId IdType="doi">10.1038/cddis.2014.466</ArticleId>
            <ArticleId IdType="pubmed">25356875</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedBookArticle>
    <BookDocument>
        <PMID Version="1">25356446</PMID>
        <ArticleIdList>
            <ArticleId IdType="bookaccession">NBK248340</ArticleId>
        </ArticleIdList>
        <Book>
            <Publisher>
                <PublisherName>Agency for Healthcare Research and Quality (US)</PublisherName>
                <PublisherLocation>Rockville (MD)</PublisherLocation>
            </Publisher>
            <BookTitle book="dbtr0610">Measuring Health-Related Quality of Life for Patients with Diabetic Retinopathy</BookTitle>
            <PubDate>
                <Year>2012</Year>
                <Month>04</Month>
                <Day>23</Day>
            </PubDate>
            <AuthorList Type="authors">
                <Author>
                    <LastName>Milne</LastName>
                    <ForeName>Andrea</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Johnson</LastName>
                    <ForeName>Jeffery A</ForeName>
                    <Initials>JA</Initials>
                </Author>
                <Author>
                    <LastName>Tennant</LastName>
                    <ForeName>Matthew</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Rudnisky</LastName>
                    <ForeName>Christopher</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author>
                    <LastName>Dryden</LastName>
                    <ForeName>Donna M</ForeName>
                    <Initials>DM</Initials>
                </Author>
            </AuthorList>
            <CollectionTitle book="hsahrqtacollect">AHRQ Technology Assessments</CollectionTitle>
            <Medium>Internet</Medium>
            <ReportNumber>Report No.: DBTR0610</ReportNumber>
        </Book>
        <Language>eng</Language>
        <Abstract>
            <AbstractText Label="OBJECTIVES">To identify and evaluate the psychometric properties of tools used to measure health-related quality of life (HRQL) in patients receiving treatment for diabetic retinopathy (DR), and to assess the effectiveness of interventions for DR to improve HRQL.</AbstractText>
            <AbstractText Label="DATA SOURCES">We conducted a systematic and comprehensive search in six electronic databases and hand searched reference lists of reviews and included studies.</AbstractText>
            <AbstractText Label="REVIEW METHODS">Study selection, quality assessment, and data extraction were completed by reviewers independently and in duplicate. We included articles that presented data on HRQL outcomes following an intervention for DR (including diabetic macular edmema (DME). Mean differences and 95 percent confidence intervals were calculated for continuous outcomes. We did not conduct any meta-analyses due to heterogeneity.</AbstractText>
            <AbstractText Label="RESULTS">We identified four validated HRQL measures: 36–Item Short Form Health Survey (SF–36), National Eye Institute Visual Functioning Questionnaire (VFQ–25 and –51), Visual Function Index (VF–14), and Diabetes Treatment Satisfaction Questionnaire (DTSQ). We also identified two tools that are currently undergoing evaluation: the Retinopathy Treatment Satisfaction Questionnaire (RetTSQ) and the Retinopathy Dependent Quality of Life (RetDQoL). Two randomized controlled trials (RCTs) reported on HRQL outcomes following anti-vascular endothelial growth factor (anti-VEGF) treatment for DME. Seven observational studies reported on HRQL outcomes following: laser photocoagulation (two), vitrectomy (two), panretinal photocoagulation versus vitrectomy (one), and phacoemulsification cataract surgery (two). The RCT comparing pegaptanib sodium versus sham reported a statistically significant improvement from baseline for the composite score of the VFQ–25 at 2 years (but not at 1 year). The three-arm RCT comparing ranibizumab monotherapy versus ranibizumab plus laser versus laser showed a statisitically significant difference for the composite score of the VFQ–25 for both anti-VEGF arms versus laser at 1 year. The strength of evidence for anti-VEGF was assessed as low. For the remaining interventions, the studies were at high risk of bias due to weak study designs (before-after and cohort studies) and poor implementation. There is insufficient evidence to determine whether one of these treatments for DR is more effective than another in improving HRQL in this patient population.</AbstractText>
            <AbstractText Label="CONCLUSIONS">We identified few HRQL measurement instruments that have been used to assess the impact of treatment in patients with DR or DME; however, the tools that have been used have been adequately evaluated. Two tools developed specifically for patients with DR are currently undergoing evaluation. In general, HRQL was improved following interventions for DR. Further research on HRQL following anti-VEGF treatment for DME is needed to confirm the results of two RCTs. The current research on the impact of other interventions for DR on HRQL is insufficient to draw conclusions about the relative effect of one intervention versus another. RCTs that assess the impact of treatments for DR should include HRQL as an outcome.</AbstractText>
        </Abstract>
        <Sections>
            <Section>
                <SectionTitle book="dbtr0610" part="fm.ack">Acknowledgments</SectionTitle>
            </Section>
            <Section>
                <SectionTitle book="dbtr0610" part="fm.s1">Peer Reviewers</SectionTitle>
            </Section>
            <Section>
                <SectionTitle book="dbtr0610" part="fm.s2">Executive Summary</SectionTitle>
            </Section>
            <Section>
                <SectionTitle book="dbtr0610" part="introduction">Introduction</SectionTitle>
            </Section>
            <Section>
                <SectionTitle book="dbtr0610" part="methods">Methods</SectionTitle>
            </Section>
            <Section>
                <SectionTitle book="dbtr0610" part="results">Results</SectionTitle>
            </Section>
            <Section>
                <SectionTitle book="dbtr0610" part="discussion">Discussion</SectionTitle>
            </Section>
            <Section>
                <SectionTitle book="dbtr0610" part="references.rl1">References</SectionTitle>
            </Section>
            <Section>
                <SectionTitle book="dbtr0610" part="abbreviations.s1">Abbreviations and Acronyms</SectionTitle>
            </Section>
            <Section>
                <SectionTitle book="dbtr0610" part="appa">Appendix A Search Strategies</SectionTitle>
            </Section>
            <Section>
                <SectionTitle book="dbtr0610" part="appb">Appendix B Inclusion/Exclusion Form</SectionTitle>
            </Section>
            <Section>
                <SectionTitle book="dbtr0610" part="appc">Appendix C Excluded Studies</SectionTitle>
            </Section>
            <Section>
                <SectionTitle book="dbtr0610" part="appd">Appendix D Characteristics of the health-related quality of life assessment tools used in studies of the treatment of diabetic retinopathy</SectionTitle>
            </Section>
            <Section>
                <SectionTitle book="dbtr0610" part="appe">Appendix E Sample HRQL assessment tools</SectionTitle>
            </Section>
            <Section>
                <SectionTitle book="dbtr0610" part="appf">Appendix F Extended study characteristics and outcomes for studies reporting the impact of interventions for diabetic retinopathy on HRQL</SectionTitle>
            </Section>
        </Sections>
    </BookDocument>
    <PubmedBookData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>10</Month>
                <Day>31</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>10</Month>
                <Day>31</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>10</Month>
                <Day>31</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25356446</ArticleId>
        </ArticleIdList>
    </PubmedBookData>
</PubmedBookArticle>

</PubmedArticleSet>
